Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease 2014
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic 2014
Identification of Potential Herbal Inhibitor of Acetylcholinesterase Associated Alzheimer’s Disorders Using Molecular Docking and Molecular Dynamics Simulation 2014
Medication Development for Agitation and Aggression in Alzheimer Disease: Review and Discussion of Recent Randomized Clinical Trial Design 2015
A clinical trial to validate event-related potential markers of Alzheimer’s disease in outpatient settings 2015
White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer’s Disease 2016
Advanced brain aging: relationship with epidemiologic and genetic risk factors, and overlap with Alzheimer disease atrophy patterns 2016
Role of transient receptor potential ankyrin 1 channels in Alzheimer’s disease 2016
CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease 2016
Vascular Dysfunction in a Transgenic Model of Alzheimer’s Disease: Effects of CB1R and CB2R Cannabinoid Agonists 2016
Cannabidiol Modulates the Expression of Alzheimer’s Disease-Related Genes in Mesenchymal Stem Cells 2017
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s Disease 2017
Drug candidates in clinical trials for Alzheimer’s disease